Stock Price Targets and Analyst Ratings

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
AAL American Airlines Group	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Thomas Wadewitz Subscribe to MarketBeat All Access for the recommendation accuracy rating	$11.59 -0.9%	$9.00 ➝ $12.00	Neutral ➝ Neutral
ABCL AbCellera Biologics	Initiated by	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Faisal Khurshid Subscribe to MarketBeat All Access for the recommendation accuracy rating	$4.03 +6.1%	$5.00	Outperform
ABDN abrdn	Upgraded by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 190 +0.1%	GBX 218	Overweight
ABNB Airbnb	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ken Gawrelski Subscribe to MarketBeat All Access for the recommendation accuracy rating	$137.00 +0.4%	$104.00 ➝ $111.00	Underweight ➝ Underweight
ACI Albertsons Companies	Reiterated by	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joe Feldman Subscribe to MarketBeat All Access for the recommendation accuracy rating	$22.72 +3.6%	$24.00	Outperform ➝ Outperform
ACVA ACV Auctions	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ronald Josey Subscribe to MarketBeat All Access for the recommendation accuracy rating	$16.13 -2.3%	$22.00 ➝ $21.00	Buy ➝ Buy
ADI Analog Devices	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Timothy Arcuri Subscribe to MarketBeat All Access for the recommendation accuracy rating	$241.81 -1.6%	$285.00 ➝ $280.00	Buy ➝ Buy
ADI Analog Devices	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Christopher Danely Subscribe to MarketBeat All Access for the recommendation accuracy rating	$241.81 -1.6%	$260.00 ➝ $290.00	Buy ➝ Buy
ADSK Autodesk	Upgraded by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating	William Jellison Subscribe to MarketBeat All Access for the recommendation accuracy rating	$315.31 -0.4%	$305.00 ➝ $375.00	Neutral ➝ Buy
ADTN ADTRAN	Initiated by	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$9.66 +1.0%		Peer Perform
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
AFL Aflac	Target Set by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Alex Scott Subscribe to MarketBeat All Access for the recommendation accuracy rating	$102.88 -1.6%	$96.00 ➝ $98.00	Underweight ➝ Underweight
AJG Arthur J. Gallagher & Co.	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Alex Scott Subscribe to MarketBeat All Access for the recommendation accuracy rating	$315.76 -0.7%	$346.00 ➝ $327.00	Equal Weight ➝ Equal Weight
ALGM Allegro MicroSystems	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Timothy Arcuri Subscribe to MarketBeat All Access for the recommendation accuracy rating	$35.40 -1.5%	$35.00 ➝ $42.00	Buy ➝ Buy
ALGT Allegiant Travel	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ravi Shanker Subscribe to MarketBeat All Access for the recommendation accuracy rating	$55.41 -8.1%	$85.00 ➝ $83.00	Equal Weight ➝ Equal Weight
ALGT Allegiant Travel	Initiated by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Thomas Wadewitz Subscribe to MarketBeat All Access for the recommendation accuracy rating	$55.41 -8.1%	$60.00 ➝ $59.00	Neutral
ALK Alaska Air Group	Initiated by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	T. Wadewitz Subscribe to MarketBeat All Access for the recommendation accuracy rating	$50.65 -0.8%	$49.00	Neutral
ALL Allstate	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Alex Scott Subscribe to MarketBeat All Access for the recommendation accuracy rating	$194.46 -1.8%	$172.00 ➝ $188.00	Underweight ➝ Underweight
ALNY Alnylam Pharmaceuticals	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Maury Raycroft Subscribe to MarketBeat All Access for the recommendation accuracy rating	$324.13 -2.3%	$328.00 ➝ $384.00	Buy ➝ Buy
AMAT Applied Materials	Reiterated by	Redburn Atlantic Subscribe to MarketBeat All Access for the recommendation accuracy rating	Timm Schulze-Melander Subscribe to MarketBeat All Access for the recommendation accuracy rating	$190.78 -0.1%	$225.00 ➝ $200.00	Buy ➝ Neutral
AMAT Applied Materials	Downgraded by	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the recommendation accuracy rating		$190.78 -0.1%	$200.00	Buy ➝ Neutral
AMAT Applied Materials	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Atif Malik Subscribe to MarketBeat All Access for the recommendation accuracy rating	$190.78 -0.1%	$190.00 ➝ $220.00	Buy ➝ Buy
AMD Advanced Micro Devices	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Danely Subscribe to MarketBeat All Access for the recommendation accuracy rating	$134.80 -2.3%	$120.00 ➝ $145.00	Neutral ➝ Neutral
AON AON	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Alex Scott Subscribe to MarketBeat All Access for the recommendation accuracy rating	$353.19 -0.4%	$415.00 ➝ $401.00	Overweight ➝ Overweight
APA APA	Target Set by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Betty Jiang Subscribe to MarketBeat All Access for the recommendation accuracy rating	$19.41 -0.6%	$19.00 ➝ $21.00	Equal Weight ➝ Equal Weight
APGE Apogee Therapeutics	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	G. Meacham Subscribe to MarketBeat All Access for the recommendation accuracy rating	$39.24 -17.3%		Buy ➝ Buy
APGE Apogee Therapeutics	Target Raised by	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$39.24 -17.3%	$100.00 ➝ $115.00	Buy
APGE Apogee Therapeutics	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		$39.24 -17.3%	$90.00	Outperform
APP AppLovin	Initiated by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Nat Schindler Subscribe to MarketBeat All Access for the recommendation accuracy rating	$345.00 +1.0%	$430.00	Outperform
AR Antero Resources	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Betty Jiang Subscribe to MarketBeat All Access for the recommendation accuracy rating	$37.08 -0.5%	$38.00 ➝ $43.00	Equal Weight ➝ Equal Weight
ARCB ArcBest	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Christian Wetherbee Subscribe to MarketBeat All Access for the recommendation accuracy rating	$79.24 -4.6%	$60.00 ➝ $90.00	Equal Weight ➝ Equal Weight
ASGN ASGN	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Surinder Thind Subscribe to MarketBeat All Access for the recommendation accuracy rating	$49.52 -6.3%	$53.00 ➝ $42.00	Hold ➝ Underperform
ATZ Aritzia	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$74.15 +0.2%	C$68.00 ➝ C$85.00	Outperform
AVGO Broadcom	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Christopher Danely Subscribe to MarketBeat All Access for the recommendation accuracy rating	$274.18 -0.4%	$285.00 ➝ $315.00	Buy ➝ Buy
AXON Axon Enterprise	Initiated by	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$802.16 +0.8%		Outperform
BAESY Bae Systems	Reiterated by	Kepler Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		$102.96 -0.5%		Hold ➝ Reduce
BHF Brighthouse Financial	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Scott Subscribe to MarketBeat All Access for the recommendation accuracy rating	$50.70 -4.9%	$76.00 ➝ $70.00	Overweight ➝ Overweight
BKNG Booking	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ken Gawrelski Subscribe to MarketBeat All Access for the recommendation accuracy rating	$5,815.92 +1.7%	$4,692.00 ➝ $5,411.00	Equal Weight ➝ Equal Weight
BKV BKV	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Betty Jiang Subscribe to MarketBeat All Access for the recommendation accuracy rating	$22.36 -1.7%	$29.00 ➝ $30.00	Overweight ➝ Overweight
BNTC Benitec Biopharma	Initiated by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$13.49 +2.4%		Buy
BOKU Boku	Initiated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 213 +1.4%	GBX 271	Buy
Elon’s BIGGEST warning yet? (Ad) Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough. Click here to see why Tesla's about to prove everyone wrong... again.
BRO Brown & Brown	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Alex Scott Subscribe to MarketBeat All Access for the recommendation accuracy rating	$107.74 -0.9%	$121.00 ➝ $111.00	Equal Weight ➝ Equal Weight
BSY Bentley Systems	Target Raised by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jason Celino Subscribe to MarketBeat All Access for the recommendation accuracy rating	$55.51 +0.3%	$56.00 ➝ $59.00	Overweight ➝ Overweight
BVS Bioventus	Initiated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ross Osborn Subscribe to MarketBeat All Access for the recommendation accuracy rating	$6.82 -2.8%	$12.00	Overweight
C Citigroup	Target Set by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Glenn Schorr Subscribe to MarketBeat All Access for the recommendation accuracy rating	$87.56 -1.3%	$77.00
C Citigroup	Reiterated by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		$87.56 -1.3%		Outperform ➝ Outperform
CACI CACI International	Upgraded by	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	L. Dipalma Subscribe to MarketBeat All Access for the recommendation accuracy rating	$506.21 +3.5%		Market Perform ➝ Outperform
CAE CAE	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Mcgarragle Subscribe to MarketBeat All Access for the recommendation accuracy rating	$29.74 +0.3%		Sector Perform ➝ Sector Perform
CAG Conagra Brands	Target Set by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Megan Alexander Subscribe to MarketBeat All Access for the recommendation accuracy rating	$20.41 -2.8%	$22.00
CALX Calix	Initiated by	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$53.33 -1.1%		Peer Perform
CAMT Camtek	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brian Chin Subscribe to MarketBeat All Access for the recommendation accuracy rating	$89.00 +0.1%	$84.00 ➝ $98.00	Buy ➝ Buy
CB Chubb	Downgraded by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Alex Scott Subscribe to MarketBeat All Access for the recommendation accuracy rating	$279.84 -1.4%	$321.00 ➝ $298.00	Overweight ➝ Equal Weight
CF CF Industries	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. Theurer Subscribe to MarketBeat All Access for the recommendation accuracy rating	$95.19 +0.6%	$91.00 ➝ $95.00	Equal Weight ➝ Equal Weight
CHYM Chime Financial	Initiated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		$31.65 +1.1%	$35.00	Hold
CHYM Chime Financial	Initiated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joseph Vafi Subscribe to MarketBeat All Access for the recommendation accuracy rating	$31.65 +1.1%	$40.00	Buy
CHYM Chime Financial	Initiated by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mark Mahaney Subscribe to MarketBeat All Access for the recommendation accuracy rating	$31.65 +1.1%	$38.00	Outperform
CHYM Chime Financial	Initiated by	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Jeffrey Subscribe to MarketBeat All Access for the recommendation accuracy rating	$31.65 +1.1%		Outperform
CHYM Chime Financial	Initiated by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ramsey El-Assal Subscribe to MarketBeat All Access for the recommendation accuracy rating	$31.65 +1.1%	$40.00	Overweight
CHYM Chime Financial	Initiated by	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$31.65 +1.1%	$38.00	Outperform
CHYM Chime Financial	Initiated by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Patrick Moley Subscribe to MarketBeat All Access for the recommendation accuracy rating	$31.65 +1.1%	$40.00	Overweight
CHYM Chime Financial	Initiated by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Timothy Chiodo Subscribe to MarketBeat All Access for the recommendation accuracy rating	$31.65 +1.1%	$35.00	Neutral
CHYM Chime Financial	Initiated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Tien-Tsin Huang Subscribe to MarketBeat All Access for the recommendation accuracy rating	$31.65 +1.1%	$40.00	Overweight
CHYM Chime Financial	Initiated by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	James Faucette Subscribe to MarketBeat All Access for the recommendation accuracy rating	$31.65 +1.1%	$39.00	Overweight
CHYM Chime Financial	Initiated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Will Nance Subscribe to MarketBeat All Access for the recommendation accuracy rating	$31.65 +1.1%	$34.00	Neutral
CMS CMS Energy	Reiterated by	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Steve Fleishman Subscribe to MarketBeat All Access for the recommendation accuracy rating	$69.60 -1.2%		Outperform ➝ Peer Perform
CNR Canadian National Railway	Target Lowered by	ATB Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$140.70 -2.4%	C$156.00 ➝ C$155.00	Sector Perform
CNX CNX Resources	Initiated by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Betty Jiang Subscribe to MarketBeat All Access for the recommendation accuracy rating	$32.17 +0.5%	$33.00	Equal Weight
COGT Cogent Biosciences	Target Raised by	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Berens Subscribe to MarketBeat All Access for the recommendation accuracy rating	$9.35 +23.4%	$16.00 ➝ $18.00	Outperform ➝ Outperform
COGT Cogent Biosciences	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Kelly Shi Subscribe to MarketBeat All Access for the recommendation accuracy rating	$9.35 +23.4%	$23.00 ➝ $28.00	Buy ➝ Buy
COIN Coinbase Global	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	James Yaro Subscribe to MarketBeat All Access for the recommendation accuracy rating	$357.10 +0.4%	$239.00 ➝ $268.00	Neutral ➝ Neutral
COMM CommScope	Initiated by	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$8.25 -4.8%		Peer Perform
CORZ Core Scientific	Reiterated by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Timothy Horan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$14.83 -17.6%		Outperform ➝ Market Perform
CORZ Core Scientific	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Gregory Lewis Subscribe to MarketBeat All Access for the recommendation accuracy rating	$14.83 -17.6%	$20.00	Buy ➝ Neutral
CP Canadian Pacific Kansas City	Target Lowered by	ATB Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$108.83 -1.0%	C$124.00 ➝ C$123.00	Outperform
CRWD CrowdStrike	Downgraded by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Rob Owens Subscribe to MarketBeat All Access for the recommendation accuracy rating	$505.46 -1.7%	$505.00	Overweight ➝ Neutral
CSX CSX	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Christian Wetherbee Subscribe to MarketBeat All Access for the recommendation accuracy rating	$33.05 -1.6%	$28.00 ➝ $35.00	Equal Weight ➝ Equal Weight
CTRA Coterra Energy	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Betty Jiang Subscribe to MarketBeat All Access for the recommendation accuracy rating	$24.83 -1.5%	$35.00 ➝ $37.00	Overweight ➝ Overweight
CTVA Corteva	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Benjamin Theurer Subscribe to MarketBeat All Access for the recommendation accuracy rating	$76.53 -0.8%	$70.00 ➝ $75.00	Equal Weight ➝ Equal Weight
CVNA Carvana	Target Raised by	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jeff Lick Subscribe to MarketBeat All Access for the recommendation accuracy rating	$357.73 +2.7%	$300.00 ➝ $375.00	Overweight ➝ Overweight
CVX Chevron	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. Jiang Subscribe to MarketBeat All Access for the recommendation accuracy rating	$147.40 -0.7%	$152.00 ➝ $156.00	Equal Weight ➝ Equal Weight
CYRX CryoPort	Target Lowered by	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Larsen Subscribe to MarketBeat All Access for the recommendation accuracy rating	$7.29 -4.8%	$13.00 ➝ $10.00	Buy ➝ Buy
CZR Caesars Entertainment	Initiated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lizzie Dove Subscribe to MarketBeat All Access for the recommendation accuracy rating	$29.42 -1.0%	$36.00	Buy
DAL Delta Air Lines	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Maheswari Subscribe to MarketBeat All Access for the recommendation accuracy rating	$50.06 -1.6%	$66.00 ➝ $63.00	Buy ➝ Buy
DAR Darling Ingredients	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lloyd Byrne Subscribe to MarketBeat All Access for the recommendation accuracy rating	$37.83 -4.1%	$45.00 ➝ $46.00	Buy ➝ Buy
DASH DoorDash	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ken Gawrelski Subscribe to MarketBeat All Access for the recommendation accuracy rating	$246.89 +3.4%	$198.00 ➝ $239.00	Equal Weight ➝ Equal Weight
DDOG Datadog	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Koji Ikeda Subscribe to MarketBeat All Access for the recommendation accuracy rating	$152.41 -1.8%	$150.00 ➝ $175.00	Buy ➝ Buy
DV DoubleVerify	Reiterated by	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating	Greg Palm Subscribe to MarketBeat All Access for the recommendation accuracy rating	$15.41	$20.00	Buy ➝ Buy
EFX Equifax	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jason Haas Subscribe to MarketBeat All Access for the recommendation accuracy rating	$264.37 +1.0%	$306.00 ➝ $310.00	Overweight ➝ Overweight
EG Everest Group	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Alex Scott Subscribe to MarketBeat All Access for the recommendation accuracy rating	$334.04 -1.0%	$394.00 ➝ $398.00	Overweight ➝ Overweight
EMR Emerson Electric	Initiated by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$138.40 -1.0%	$150.00	Buy
EPD Enterprise Products Partners	Initiated by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$31.34 -0.5%	$33.00	Hold
Here's the last trade you should make before heading out for the weekend tomorrow. (Ad) Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning. Give me the details
EQR Equity Residential	Upgraded by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Steve Sakwa Subscribe to MarketBeat All Access for the recommendation accuracy rating	$66.67 -0.3%	$74.00 ➝ $75.00	In-Line ➝ Outperform
EQT EQT	Initiated by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Betty Jiang Subscribe to MarketBeat All Access for the recommendation accuracy rating	$56.15 +1.5%	$65.00	Overweight
ESNT Essent Group	Downgraded by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating	Bose George Subscribe to MarketBeat All Access for the recommendation accuracy rating	$59.83 -3.3%	$65.00 ➝ $67.00	Outperform ➝ Market Perform
ET Energy Transfer	Initiated by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$17.75 -1.2%	$22.00	Buy
ET Energy Transfer	Initiated by	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$17.75 -1.2%		Buy
EXE Expand Energy	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. Jiang Subscribe to MarketBeat All Access for the recommendation accuracy rating	$108.90 +0.1%	$122.00 ➝ $139.00	Overweight ➝ Overweight
EXPE Expedia Group	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ken Gawrelski Subscribe to MarketBeat All Access for the recommendation accuracy rating	$177.80 +0.7%	$149.00 ➝ $178.00	Equal Weight ➝ Equal Weight
FC Franklin Covey	Target Lowered by	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jeff Martin Subscribe to MarketBeat All Access for the recommendation accuracy rating	$21.34 -3.4%	$30.00 ➝ $27.00	Buy ➝ Buy
FFH Fairfax Financial	Target Raised by	Raymond James Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Boland Subscribe to MarketBeat All Access for the recommendation accuracy rating	C$2,453.09 +0.9%	C$2,600.00 ➝ C$2,900.00	Outperform
FFIV F5	Initiated by	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$299.26 -0.3%		Outperform
FG F&G Annuities & Life	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mark Devries Subscribe to MarketBeat All Access for the recommendation accuracy rating	$31.19 -4.1%	$40.00 ➝ $37.00	Equal Weight ➝ Equal Weight
FIHL Fidelis Insurance	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Alex Scott Subscribe to MarketBeat All Access for the recommendation accuracy rating	$15.92 -1.7%	$16.00 ➝ $17.00	Equal Weight ➝ Equal Weight
FIZZ National Beverage	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Peter Grom Subscribe to MarketBeat All Access for the recommendation accuracy rating	$46.65 -0.6%	$42.00 ➝ $45.00	Sell ➝ Sell
FMC FMC	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. Theurer Subscribe to MarketBeat All Access for the recommendation accuracy rating	$43.20 -2.3%	$48.00 ➝ $49.00	Overweight ➝ Overweight
GEV GE Vernova	Initiated by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Amit Mehrotra Subscribe to MarketBeat All Access for the recommendation accuracy rating	$530.83 +2.7%	$614.00	Buy
GFS GlobalFoundries	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Christopher Danely Subscribe to MarketBeat All Access for the recommendation accuracy rating	$38.95 -2.1%	$35.00 ➝ $42.00	Neutral ➝ Neutral
GXO GXO Logistics	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Christian Wetherbee Subscribe to MarketBeat All Access for the recommendation accuracy rating	$49.84 -2.4%	$48.00 ➝ $57.00	Overweight ➝ Overweight
HELE Helen of Troy	Target Lowered by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Susan Anderson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$30.10 -7.8%	$53.00 ➝ $47.00	Buy ➝ Buy
HG Hamilton Insurance Group	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Alex Scott Subscribe to MarketBeat All Access for the recommendation accuracy rating	$21.21 -0.8%	$21.00 ➝ $25.00	Overweight ➝ Overweight
HIG The Hartford Insurance Group	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Scott Subscribe to MarketBeat All Access for the recommendation accuracy rating	$123.36 -1.3%	$145.00 ➝ $142.00	Overweight ➝ Overweight
HOOD Robinhood Markets	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Will Nance Subscribe to MarketBeat All Access for the recommendation accuracy rating	$93.46 -1.0%	$91.00 ➝ $104.00	Buy ➝ Buy
HOOD Robinhood Markets	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Christopher Allen Subscribe to MarketBeat All Access for the recommendation accuracy rating	$93.46 -1.0%	$50.00 ➝ $100.00	Neutral ➝ Neutral
HR.UN H&R Real Estate Investment Trust	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$12.06 -3.2%	C$12.00 ➝ C$14.00	Sector Perform
HR.UN H&R Real Estate Investment Trust	Target Raised by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$12.06 -3.2%	C$11.50 ➝ C$14.50	Buy
IBKR Interactive Brokers Group	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Allen Subscribe to MarketBeat All Access for the recommendation accuracy rating	$57.78 -0.3%	$53.75 ➝ $60.00	Buy ➝ Buy
INTC Intel	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Christopher Danely Subscribe to MarketBeat All Access for the recommendation accuracy rating	$22.00 -2.2%	$21.00 ➝ $24.00	Neutral ➝ Neutral
INTU Intuit	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Keith Weiss Subscribe to MarketBeat All Access for the recommendation accuracy rating	$783.61 +0.4%	$785.00 ➝ $900.00	Overweight ➝ Overweight
INTZ Intrusion	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Scott Buck Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2.56 -0.4%	$1.50 ➝ $2.50	Neutral ➝ Neutral
IONQ IonQ	Target Raised by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Williams Subscribe to MarketBeat All Access for the recommendation accuracy rating	$45.31 +2.1%	$50.00 ➝ $55.00	Buy ➝ Buy
JBHT J.B. Hunt Transport Services	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ravi Shanker Subscribe to MarketBeat All Access for the recommendation accuracy rating	$149.56 -2.2%	$160.00 ➝ $155.00	Equal Weight ➝ Equal Weight
JBLU JetBlue Airways	Target Set by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Atul Maheswari Subscribe to MarketBeat All Access for the recommendation accuracy rating	$4.30 -3.6%	$3.00	Sell
JPM JPMorgan Chase & Co.	Target Set by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Glenn Schorr Subscribe to MarketBeat All Access for the recommendation accuracy rating	$291.95 -1.4%	$298.00	Outperform ➝ Outperform
JPM JPMorgan Chase & Co.	Reiterated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$291.95 -1.4%		Overweight ➝ Overweight
JPM JPMorgan Chase & Co.	Target Set by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Betsy Graseck Subscribe to MarketBeat All Access for the recommendation accuracy rating	$291.95 -1.4%	$240.00	Equal Weight ➝ Equal Weight
JPM JPMorgan Chase & Co.	Target Set by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Keith Horowitz Subscribe to MarketBeat All Access for the recommendation accuracy rating	$291.95 -1.4%	$275.00	Buy ➝ Buy
JSPR Jasper Therapeutics	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Pete Stavropoulos Subscribe to MarketBeat All Access for the recommendation accuracy rating	$3.04 -55.1%		Overweight ➝ Neutral
JSPR Jasper Therapeutics	Reiterated by	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	Matt Phipps Subscribe to MarketBeat All Access for the recommendation accuracy rating	$3.04 -55.1%		Outperform ➝ Market Perform
JSPR Jasper Therapeutics	Target Lowered by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Emily Bodnar Subscribe to MarketBeat All Access for the recommendation accuracy rating	$3.04 -55.1%	$40.00 ➝ $20.00	Buy ➝ Buy
JSPR Jasper Therapeutics	Target Lowered by	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Justin Zelin Subscribe to MarketBeat All Access for the recommendation accuracy rating	$3.04 -55.1%	$64.00 ➝ $20.00	Buy ➝ Buy
JXN Jackson Financial	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Alex Scott Subscribe to MarketBeat All Access for the recommendation accuracy rating	$87.99 -1.1%	$108.00 ➝ $114.00	Overweight ➝ Overweight
KALV KalVista Pharmaceuticals	Target Raised by	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joseph Schwartz Subscribe to MarketBeat All Access for the recommendation accuracy rating	$15.06 +25.7%	$18.00 ➝ $20.00	Outperform ➝ Outperform
KLAC KLA	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Atif Malik Subscribe to MarketBeat All Access for the recommendation accuracy rating	$912.62 -1.3%	$835.00 ➝ $1,035.00	Buy ➝ Buy
KMI Kinder Morgan	Target Set by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jason Gabelman Subscribe to MarketBeat All Access for the recommendation accuracy rating	$28.36 -0.2%	$34.00
KMI Kinder Morgan	Initiated by	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$28.36 -0.2%		Buy ➝ Buy
KMI Kinder Morgan	Initiated by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$28.36 -0.2%	$34.00	Buy
LC LendingClub	Initiated by	Citizens Jmp Subscribe to MarketBeat All Access for the recommendation accuracy rating		$12.23 -2.7%		Market Perform
LEU Centrus Energy	Initiated by	Northland Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$183.65 +4.6%	$205.00	Outperform
LGIH LGI Homes	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		$52.16 -4.2%	$93.00	Neutral
LNT Alliant Energy	Upgraded by	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Steve Fleishman Subscribe to MarketBeat All Access for the recommendation accuracy rating	$61.95 +0.7%	$68.00	Peer Perform ➝ Outperform
LRCX Lam Research	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Atif Malik Subscribe to MarketBeat All Access for the recommendation accuracy rating	$98.14 -0.7%	$87.00 ➝ $108.00	Buy ➝ Buy
Is Elon's empire crumbling? (Ad) The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd. Click here to see the Tesla shock that could blindside everyone.
LUV Southwest Airlines	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	T. Wadewitz Subscribe to MarketBeat All Access for the recommendation accuracy rating	$33.81 -0.8%	$27.00 ➝ $34.00	Neutral ➝ Neutral
LVS Las Vegas Sands	Initiated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lizzie Dove Subscribe to MarketBeat All Access for the recommendation accuracy rating	$48.36 +0.3%	$52.00	Neutral
LYFT Lyft	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ken Gawrelski Subscribe to MarketBeat All Access for the recommendation accuracy rating	$16.07 -0.5%	$13.00 ➝ $14.00	Equal Weight ➝ Equal Weight
MCHP Microchip Technology	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Christopher Danely Subscribe to MarketBeat All Access for the recommendation accuracy rating	$71.48 -2.2%	$68.00 ➝ $90.00	Buy ➝ Buy
MCHP Microchip Technology	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Pradeep Ramani Subscribe to MarketBeat All Access for the recommendation accuracy rating	$71.48 -2.2%	$65.00 ➝ $85.00	Buy ➝ Buy
MCO Moody's	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Toni Kaplan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$502.51 -0.5%	$493.00 ➝ $498.00	Equal Weight ➝ Equal Weight
MET MetLife	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Alex Scott Subscribe to MarketBeat All Access for the recommendation accuracy rating	$79.20 -1.8%	$88.00 ➝ $94.00	Overweight ➝ Overweight
MFA MFA Financial	Initiated by	Jones Trading Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jason Weaver Subscribe to MarketBeat All Access for the recommendation accuracy rating	$9.53 -2.2%		Hold
MGM MGM Resorts International	Initiated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lizzie Dove Subscribe to MarketBeat All Access for the recommendation accuracy rating	$37.04 -1.5%	$34.00	Sell
MMC Marsh & McLennan Companies	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Alex Scott Subscribe to MarketBeat All Access for the recommendation accuracy rating	$213.04 -0.9%	$249.00 ➝ $233.00	Equal Weight ➝ Equal Weight
MNPR Monopar Therapeutics	Initiated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Kristen Kluska Subscribe to MarketBeat All Access for the recommendation accuracy rating	$37.20 +2.6%	$74.00	Overweight
MNY MoneyHero	Initiated by	Greenridge Global Subscribe to MarketBeat All Access for the recommendation accuracy rating	William Gregozeski Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.04 -2.8%	$4.00	Buy
MOS Mosaic	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. Theurer Subscribe to MarketBeat All Access for the recommendation accuracy rating	$37.68 +1.1%	$40.00 ➝ $46.00	Overweight ➝ Overweight
MP MP Materials	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Laurence Alexander Subscribe to MarketBeat All Access for the recommendation accuracy rating	$31.10 -2.3%	$32.00 ➝ $33.00	Buy ➝ Hold
MSI Motorola Solutions	Initiated by	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$426.20 +0.3%		Peer Perform
MTG MGIC Investment	Target Raised by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating	Bose George Subscribe to MarketBeat All Access for the recommendation accuracy rating	$27.41 -3.9%	$26.00 ➝ $27.00	Market Perform ➝ Market Perform
MTSI MACOM Technology Solutions	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	W. Stein Subscribe to MarketBeat All Access for the recommendation accuracy rating	$138.04 -1.9%	$136.00 ➝ $154.00	Buy ➝ Buy
MUR Murphy Oil	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. Jiang Subscribe to MarketBeat All Access for the recommendation accuracy rating	$23.88 -2.4%	$22.00 ➝ $23.00	Underweight ➝ Underweight
NAK Northern Dynasty Minerals	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Heiko Ihle Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.79 +27.9%	$1.30 ➝ $2.50	Buy ➝ Buy
NCLH Norwegian Cruise Line	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Katz Subscribe to MarketBeat All Access for the recommendation accuracy rating	$21.48 -2.3%	$24.00 ➝ $29.00	Buy ➝ Buy
NMIH NMI	Downgraded by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. George Subscribe to MarketBeat All Access for the recommendation accuracy rating	$41.19 -4.5%	$42.00 ➝ $43.00	Outperform ➝ Market Perform
NNE Nano Nuclear Energy	Initiated by	Northland Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$34.14 +1.6%	$40.00	Outperform
NTR Nutrien	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. Theurer Subscribe to MarketBeat All Access for the recommendation accuracy rating	$60.75 +1.0%	$61.00 ➝ $64.00	Equal Weight ➝ Equal Weight
NVDA NVIDIA	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Atif Malik Subscribe to MarketBeat All Access for the recommendation accuracy rating	$158.24 -0.7%	$180.00 ➝ $190.00	Buy ➝ Buy
NVT nVent Electric	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joe Ritchie Subscribe to MarketBeat All Access for the recommendation accuracy rating	$74.51 -0.5%	$78.00 ➝ $87.00	Buy ➝ Buy
NXPI NXP Semiconductors	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Danely Subscribe to MarketBeat All Access for the recommendation accuracy rating	$226.00 -2.6%	$210.00 ➝ $275.00	Buy ➝ Buy
ODFL Old Dominion Freight Line	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Christian Wetherbee Subscribe to MarketBeat All Access for the recommendation accuracy rating	$164.31 -3.9%	$150.00 ➝ $160.00	Underweight ➝ Underweight
OKE ONEOK	Initiated by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$80.18 -2.4%	$91.00	Hold
OKTA Okta	Initiated by	Arete Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$97.40 -1.7%	$83.00	Sell
OKTA Okta	Initiated by	Arete Subscribe to MarketBeat All Access for the recommendation accuracy rating		$97.40 -1.7%	$83.00	Sell
OLO OLO	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Jeffries Subscribe to MarketBeat All Access for the recommendation accuracy rating	$10.14 +0.2%	$8.00 ➝ $10.25	Neutral ➝ Neutral
OLO OLO	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Matthew Hedberg Subscribe to MarketBeat All Access for the recommendation accuracy rating	$10.14 +0.2%	$10.25	Outperform ➝ Sector Perform
ON ON Semiconductor	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Christopher Danely Subscribe to MarketBeat All Access for the recommendation accuracy rating	$54.61 -3.5%	$40.00 ➝ $60.00	Neutral ➝ Neutral
ON ON Semiconductor	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Pradeep Ramani Subscribe to MarketBeat All Access for the recommendation accuracy rating	$54.61 -3.5%	$45.00 ➝ $55.00	Neutral ➝ Neutral
OR OR Royalties	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	T. Jakusconek Subscribe to MarketBeat All Access for the recommendation accuracy rating	$27.25 +4.7%	$26.00 ➝ $28.00	Sector Outperform ➝ Sector Outperform
OVV Ovintiv	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Betty Jiang Subscribe to MarketBeat All Access for the recommendation accuracy rating	$39.29 -1.6%	$53.00 ➝ $55.00	Overweight ➝ Overweight
PAHC Phibro Animal Health	Upgraded by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ekaterina Knyazkova Subscribe to MarketBeat All Access for the recommendation accuracy rating	$29.90 +6.8%	$25.00 ➝ $35.00	Neutral ➝ Overweight
PEG Public Service Enterprise Group	Upgraded by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	William Appicelli Subscribe to MarketBeat All Access for the recommendation accuracy rating	$82.30 +1.4%	$86.00 ➝ $97.00	Neutral ➝ Buy
PFG Principal Financial Group	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Alex Scott Subscribe to MarketBeat All Access for the recommendation accuracy rating	$80.19 -1.0%	$76.00 ➝ $80.00	Underweight ➝ Underweight
PGR Progressive	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Alex Scott Subscribe to MarketBeat All Access for the recommendation accuracy rating	$253.38 -3.2%	$297.00 ➝ $287.00	Equal Weight ➝ Equal Weight
PGR Progressive	Downgraded by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Bob Huang Subscribe to MarketBeat All Access for the recommendation accuracy rating	$253.38 -3.2%	$330.00 ➝ $290.00	Overweight ➝ Equal Weight
PLSE Pulse Biosciences	Initiated by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Suraj Kalia Subscribe to MarketBeat All Access for the recommendation accuracy rating	$15.81 +3.3%	$22.00	Outperform
PPL Pembina Pipeline	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$49.57 -2.3%	C$58.00 ➝ C$57.00	Overweight
PRCT PROCEPT BioRobotics	Initiated by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Suraj Kalia Subscribe to MarketBeat All Access for the recommendation accuracy rating	$56.97 -1.6%		Market Perform
PRU Prudential Financial	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Alex Scott Subscribe to MarketBeat All Access for the recommendation accuracy rating	$106.48 -2.4%	$109.00 ➝ $119.00	Equal Weight ➝ Equal Weight
PTC PTC	Reiterated by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jason Celino Subscribe to MarketBeat All Access for the recommendation accuracy rating	$174.82 -0.7%	$185.00 ➝ $192.00	Overweight ➝ Overweight
QCOM QUALCOMM	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Christopher Danely Subscribe to MarketBeat All Access for the recommendation accuracy rating	$158.09 -2.5%	$145.00 ➝ $170.00	Neutral ➝ Neutral
RBLX Roblox	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$107.71 +4.0%		Buy ➝ Buy
RCL Royal Caribbean Cruises	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Katz Subscribe to MarketBeat All Access for the recommendation accuracy rating	$328.55 -1.8%	$235.00 ➝ $315.00	Hold ➝ Hold
RDN Radian Group	Reiterated by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating	Bose George Subscribe to MarketBeat All Access for the recommendation accuracy rating	$35.66 -3.1%	$38.00	Outperform ➝ Market Perform
Presidential Bombshell: $150T Resource to Be Released as soon as this Summer? (Ad) Something extraordinary is happening in Washington. For the first time in over a century, a sitting President could release a national treasure that's been tied up in red tape, for generations. I'm talking about a $150 trillion American asset that's scattered across all 50 states. While the mainstream media focuses on political theater, this story is quietly developing behind closed doors. We recently interviewed Rickards to get the full story and understand how everyday Americans can pre
RJF Raymond James Financial	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Christopher Allen Subscribe to MarketBeat All Access for the recommendation accuracy rating	$157.34 -1.7%	$150.00 ➝ $165.00	Neutral ➝ Neutral
RNR RenaissanceRe	Upgraded by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Scott Subscribe to MarketBeat All Access for the recommendation accuracy rating	$239.12 -0.7%	$231.00 ➝ $256.00	Underweight ➝ Equal Weight
ROK Rockwell Automation	Initiated by	CICC Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$338.67 -2.4%	$381.00	Outperform
RR Rolls-Royce Holdings plc	Reiterated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 962.60 +0.9%	GBX 1,040	Overweight
RRC Range Resources	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Betty Jiang Subscribe to MarketBeat All Access for the recommendation accuracy rating	$38.78 +0.4%	$39.00 ➝ $44.00	Equal Weight ➝ Equal Weight
RUN Sunrun	Upgraded by	BNP Paribas Exane Subscribe to MarketBeat All Access for the recommendation accuracy rating		$11.11 +5.8%	$21.00	Neutral ➝ Outperform
RXO RXO	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ravi Shanker Subscribe to MarketBeat All Access for the recommendation accuracy rating	$16.17 -3.9%	$23.00 ➝ $21.00	Equal Weight ➝ Equal Weight
RYAN Ryan Specialty	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Alex Scott Subscribe to MarketBeat All Access for the recommendation accuracy rating	$66.38 -0.6%	$83.00 ➝ $79.00	Overweight ➝ Overweight
RYTM Rhythm Pharmaceuticals	Initiated by	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Faisal Khurshid Subscribe to MarketBeat All Access for the recommendation accuracy rating	$66.39 +0.9%	$88.00	Outperform
S32 South32	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 145.40 -1.9%	GBX 125	Hold
SAIA Saia	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Christian Wetherbee Subscribe to MarketBeat All Access for the recommendation accuracy rating	$285.89 -3.0%	$260.00 ➝ $290.00	Equal Weight ➝ Equal Weight
SAIL SailPoint	Initiated by	Arete Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$21.97 -0.9%	$16.00	Sell
SAIL SailPoint	Initiated by	Arete Subscribe to MarketBeat All Access for the recommendation accuracy rating		$21.97 -0.9%	$16.00	Sell
SCHW Charles Schwab	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Allen Subscribe to MarketBeat All Access for the recommendation accuracy rating	$92.62 +1.2%	$102.00 ➝ $105.00	Buy ➝ Buy
SDR Schroders	Reiterated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 368.20 +1.4%	GBX 373	Neutral
SF Stifel Financial	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Christopher Allen Subscribe to MarketBeat All Access for the recommendation accuracy rating	$107.54 -1.5%	$94.00 ➝ $115.00	Neutral ➝ Neutral
SGRO SEGRO	Reiterated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 667.60 -0.2%	GBX 885	Overweight
SHLS Shoals Technologies Group	Upgraded by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Julien Dumoulin-Smith Subscribe to MarketBeat All Access for the recommendation accuracy rating	$6.30 +5.4%	$4.90 ➝ $7.20	Hold ➝ Buy
SJM J. M. Smucker	Initiated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Nik Modi Subscribe to MarketBeat All Access for the recommendation accuracy rating	$103.57 -0.5%	$130.00	Outperform
SKM SK Telecom	Downgraded by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	E. Cha Subscribe to MarketBeat All Access for the recommendation accuracy rating	$21.77 -7.7%		Neutral ➝ Sell
SLF Sun Life Financial	Downgraded by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$62.75 -4.1%		Equal Weight ➝ Underweight
SLP Simulations Plus	Target Lowered by	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Larsen Subscribe to MarketBeat All Access for the recommendation accuracy rating	$16.83 -5.2%	$41.00 ➝ $25.00	Buy ➝ Buy
SMR NuScale Power	Initiated by	Northland Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$36.82 +2.6%	$35.00	Market Perform
SPGI S&P Global	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Toni Kaplan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$530.03 +0.1%	$587.00 ➝ $595.00	Overweight ➝ Overweight
STLA Stellantis	Downgraded by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Jacks Subscribe to MarketBeat All Access for the recommendation accuracy rating	$9.81 -4.8%	$16.50 ➝ $11.75	Buy ➝ Neutral
STZ Constellation Brands	Upgraded by	Raymond James Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$170.51 -1.1%		Strong-Buy
STZ Constellation Brands	Reiterated by	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$170.51 -1.1%		Hold ➝ Hold
STZ Constellation Brands	Upgraded by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Kaumil Gajrawala Subscribe to MarketBeat All Access for the recommendation accuracy rating	$170.51 -1.1%	$194.00 ➝ $205.00	Hold ➝ Buy
T AT&T	Initiated by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Funk Subscribe to MarketBeat All Access for the recommendation accuracy rating	$28.39 +0.1%	$32.00	Buy
TBBK Bancorp	Upgraded by	Raymond James Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$59.52 +1.1%		Strong-Buy
TBBK Bancorp	Reiterated by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$59.52 +1.1%		Buy ➝ Buy
TBBK Bancorp	Upgraded by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$59.52 +1.1%		Buy
TEAM Atlassian	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$216.05 +1.2%		Hold ➝ Hold
TIMB TIM	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mathieu Robilliard Subscribe to MarketBeat All Access for the recommendation accuracy rating	$20.41 -1.2%	$17.50 ➝ $20.00	Equal Weight ➝ Equal Weight
TKO Taseko Mines	Target Raised by	Paradigm Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$4.48 +1.8%	C$4.50 ➝ C$5.25	Buy
TMUS T-Mobile US	Upgraded by	Redburn Atlantic Subscribe to MarketBeat All Access for the recommendation accuracy rating	Steve Malcolm Subscribe to MarketBeat All Access for the recommendation accuracy rating	$237.63 -1.3%	$228.00	Sell ➝ Neutral
TMUS T-Mobile US	Upgraded by	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the recommendation accuracy rating		$237.63 -1.3%	$228.00	Sell ➝ Neutral
TMUS T-Mobile US	Initiated by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Funk Subscribe to MarketBeat All Access for the recommendation accuracy rating	$237.63 -1.3%	$255.00	Neutral
TRGP Targa Resources	Initiated by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$172.65 -0.5%	$192.00	Hold
TRGP Targa Resources	Initiated by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$172.65 -0.5%		Hold
TRV Travelers Companies	Downgraded by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Alex Scott Subscribe to MarketBeat All Access for the recommendation accuracy rating	$258.83 -2.0%	$280.00 ➝ $274.00	Overweight ➝ Equal Weight
TSLA Tesla	Downgraded by	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jed Dorsheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	$293.94 -6.8%		Outperform ➝ Market Perform
TTMI TTM Technologies	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	William Stein Subscribe to MarketBeat All Access for the recommendation accuracy rating	$41.88 -4.9%	$41.00 ➝ $48.00	Buy ➝ Buy
TXN Texas Instruments	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Christopher Danely Subscribe to MarketBeat All Access for the recommendation accuracy rating	$213.41 -1.2%	$220.00 ➝ $260.00	Buy ➝ Buy
TXN Texas Instruments	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Timothy Arcuri Subscribe to MarketBeat All Access for the recommendation accuracy rating	$213.41 -1.2%	$215.00 ➝ $245.00	Buy ➝ Buy
U Unity Software	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Alec Brondolo Subscribe to MarketBeat All Access for the recommendation accuracy rating	$27.94 +6.9%	$19.00 ➝ $24.00	Equal Weight ➝ Equal Weight
UAL United Airlines	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	T. Wadewitz Subscribe to MarketBeat All Access for the recommendation accuracy rating	$81.11 -1.5%	$105.00 ➝ $103.00	Buy ➝ Buy
UBER Uber Technologies	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ken Gawrelski Subscribe to MarketBeat All Access for the recommendation accuracy rating	$96.67 +3.2%	$100.00 ➝ $120.00	Overweight ➝ Overweight
UDR United Dominion Realty Trust	Target Set by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Steve Sakwa Subscribe to MarketBeat All Access for the recommendation accuracy rating	$40.91 +0.3%	$45.00 ➝ $46.00	In-Line ➝ Outperform
ULCC Frontier Group	Target Set by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Atul Maheswari Subscribe to MarketBeat All Access for the recommendation accuracy rating	$3.96 -4.6%	$4.00	Neutral ➝ Neutral
ULTA Ulta Beauty	Target Raised by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Baker Subscribe to MarketBeat All Access for the recommendation accuracy rating	$475.99 -0.4%	$485.00 ➝ $550.00	Buy ➝ Buy
UNM Unum Group	Target Set by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Alex Scott Subscribe to MarketBeat All Access for the recommendation accuracy rating	$81.68 -0.5%	$89.00 ➝ $96.00	Overweight ➝ Overweight
UNP Union Pacific	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ravi Shanker Subscribe to MarketBeat All Access for the recommendation accuracy rating	$235.38 -0.4%	$220.00 ➝ $215.00	Equal Weight ➝ Equal Weight
URGN Urogen Pharma	Reiterated by	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jason Kolbert Subscribe to MarketBeat All Access for the recommendation accuracy rating	$13.49 -0.7%	$25.00	Buy ➝ Buy
USB U.S. Bancorp	Upgraded by	Raymond James Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Rose Subscribe to MarketBeat All Access for the recommendation accuracy rating	$47.78 -0.3%	$51.00 ➝ $57.00	Outperform ➝ Strong-Buy
VFS VinFast Auto	Reiterated by	Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Mcilree Subscribe to MarketBeat All Access for the recommendation accuracy rating	$3.51 -3.6%	$5.50	Buy ➝ Buy
VIK Viking	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Katz Subscribe to MarketBeat All Access for the recommendation accuracy rating	$55.11 -0.6%	$45.00 ➝ $52.00	Hold ➝ Hold
VOYA Voya Financial	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Scott Subscribe to MarketBeat All Access for the recommendation accuracy rating	$72.39 -0.7%	$70.00 ➝ $75.00	Equal Weight ➝ Equal Weight
VOYG Voyager Technologies	Initiated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Seth Seifman Subscribe to MarketBeat All Access for the recommendation accuracy rating	$39.20 -7.4%	$52.00	Overweight
VOYG Voyager Technologies	Initiated by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Kristine Liwag Subscribe to MarketBeat All Access for the recommendation accuracy rating	$39.20 -7.4%	$46.00	Equal Weight
VOYG Voyager Technologies	Initiated by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Strauss Subscribe to MarketBeat All Access for the recommendation accuracy rating	$39.20 -7.4%	$45.00	Equal Weight
VOYG Voyager Technologies	Initiated by	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Myles Walton Subscribe to MarketBeat All Access for the recommendation accuracy rating	$39.20 -7.4%	$50.00	Outperform
VOYG Voyager Technologies	Initiated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Sheila Kahyaoglu Subscribe to MarketBeat All Access for the recommendation accuracy rating	$39.20 -7.4%	$50.00	Buy
VOYG Voyager Technologies	Initiated by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ronald Epstein Subscribe to MarketBeat All Access for the recommendation accuracy rating	$39.20 -7.4%	$50.00	Buy
VOYG Voyager Technologies	Initiated by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Leshock Subscribe to MarketBeat All Access for the recommendation accuracy rating	$39.20 -7.4%	$50.00	Overweight
VZ Verizon Communications	Initiated by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Funk Subscribe to MarketBeat All Access for the recommendation accuracy rating	$42.80 -1.7%	$45.00	Neutral
WFC Wells Fargo & Company	Downgraded by	Raymond James Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Long Subscribe to MarketBeat All Access for the recommendation accuracy rating	$82.34 -1.5%		Strong-Buy ➝ Market Perform
WIZZ Wizz Air	Reiterated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 1,085 +0.1%		Neutral
WMB Williams Companies	Initiated by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$58.52 -0.2%	$67.00	Buy
WMG Warner Music Group	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Alexia Quadrani Subscribe to MarketBeat All Access for the recommendation accuracy rating	$29.42 +0.1%	$32.00 ➝ $33.00	Overweight ➝ Overweight
WNS WNS	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mayank Tandon Subscribe to MarketBeat All Access for the recommendation accuracy rating	$74.70 +14.3%		Buy ➝ Hold
WNS WNS	Downgraded by	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	Maggie Nolan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$74.70 +14.3%		Outperform ➝ Market Perform
WRB W.R. Berkley	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Alex Scott Subscribe to MarketBeat All Access for the recommendation accuracy rating	$70.68 -1.1%	$62.00 ➝ $66.00	Underweight ➝ Underweight
WTW Willis Towers Watson Public	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Alex Scott Subscribe to MarketBeat All Access for the recommendation accuracy rating	$305.30 -0.4%	$316.00 ➝ $305.00	Underweight ➝ Underweight
WYNN Wynn Resorts	Initiated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lizzie Dove Subscribe to MarketBeat All Access for the recommendation accuracy rating	$108.67 +2.9%	$122.00	Buy
XPO XPO	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Christian Wetherbee Subscribe to MarketBeat All Access for the recommendation accuracy rating	$129.69 -1.8%	$116.00 ➝ $144.00	Overweight ➝ Overweight
XPO XPO	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Scott Schneeberger Subscribe to MarketBeat All Access for the recommendation accuracy rating	$129.69 -1.8%	$126.00 ➝ $150.00	Outperform ➝ Outperform
XPO XPO	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ken Hoexter Subscribe to MarketBeat All Access for the recommendation accuracy rating	$129.69 -1.8%	$139.00 ➝ $150.00	Buy ➝ Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 09:21 PM ET.

Stock Ratings and Recommendations: Understanding Analyst Ratings

Written by MarketBeat Staff

July 5, 2023

Key Points

Stock analysts give ratings to companies based on their research and insights.
Analysis comes from the buy side (fund companies, investment managers) or sell side (brokers, banks).
Analysts use different methodologies, so investors should always look into why a particular rating was given.
5 stocks we like better than EXA)

You'll often hear a particular stock called a "buy" or "sell," but who exactly makes these calls? Ratings and recommendations come from stock analysts, who research different securities and work for various institutions, brokerage firms and other financial companies.

Analyst ratings are designed to give additional information to investors beyond just what the company is saying, but are analyst ratings reliable? In this article, we'll discuss how to read analyst ratings, what goes into their decision-making process and how potential conflicts of interest influence analyst stock ratings.

What Are Analyst Ratings?

A stock rating is a simple heuristic given by analysts who review the firm's financial statements, listen to conference calls, chat with company executives and compare the stock to others in the industry or sector. Finally, an analyst uses all this information to produce a simple recommendation and price target.

When a public analyst goes on CNBC or the "Wall Street Journal" to give a "buy" or "sell" rating on a particular stock, they take all their research and pare it down into a simple designation. While there's no true consensus on what constitutes a buy or sell rating, an analyst usually does have "skin in the game" when devising ratings.

Ratings often pair with price targets, which put a hard number on what the analysts believe the company stock should be worth. So, for example, you might see an analyst report something like, "Buy NVIDIA Inc. (NASDAQ: NVDA), price target $350," which means that particular analyst believes investors should buy NVDA shares up to a price of $350 per share.

Analyst ratings infographic: What you need to know

What Does a Stock Analyst Do?

A stock analyst is a market professional with the skills to interpret financial data and the connections within companies to speak on the record with higher-ups. Analysts generally fall into one of two different camps: buy-side or sell-side. These positions will seem similar, but they tend to be employed by various institutions and have different responsibilities in their particular market "territories."

Buy-side analysts: Analysts on the buy side tend to work for funds, such as ETF providers or hedge funds. They don't dig as deeply into company financial data or conference calls as sell-siders. Instead, they focus on general areas or industries where their funds have vested interests. In addition, buy-side analysts often forge relationships with sell-side analysts for individual stock research. A buy-side analyst's primary goal is to find and utilize the most accurate and dependable sell-side analysts.
Sell-side analysts: If buy-side analysts work for funds (i.e., institutions that buy securities), you can probably guess which type of institution employs sell-side analysts. Brokers, banks and other firms that sell securities to investors use sell-side analysts to give reports to the public. While buy-side analysts also give ratings and price targets, the reported "buy" and "sell" ratings in financial media typically come from folks on the sell side.

Buy and sell-side analysts often use different rating systems when making their recommendations. You might even find two sell-side analysts with similar "buy" recommendations with vastly different price targets in the same stock. As a result, you'll need to familiarize yourself with the various methodologies analysts use to utilize their research correctly.

What Ratings Do Analysts Give?

Stock analyst ratings don't follow a strict structure, although most have roughly the same grading system for the securities they review. The labels may differ slightly (i.e., overweight vs. outperform), but the five most common analyst ratings go like this.

Buy

Analysts bullish on a particular security will give it a "buy" rating and set a price target above the current market price. In addition, if the analyst considers the stock one of the best in the industry or sector, you'll sometimes see a "strong buy" rating attached.

Hold

A "hold" rating is typically the lowest rating a sell-side analyst gives a stock. "Hold" means the analyst projects the stock to meet the return of the market averages, making it an unspectacular investment. Stocks rated "hold" may still have a price target above the current price, but it's not likely to surpass the return of a major index like the S&P 500.

Sell

Analysts are usually apprehensive about giving a stock a "sell" rating. For example, suppose a "hold" rating indicates indecision over the stock's future. In this scenario, a "sell" rating is issued when an analyst finds something unappealing, such as questionable accounting tactics or cratering sales growth.

Underperform

Analysts won't always give a firm "buy" or "sell" rating on stock but will instead label it "underperform" or "outperform." "Underperform" means the analyst expects the stock not to keep up with the market. It doesn't necessarily mean the analyst predicts a crash but indicates a lack of confidence in the shares.

Outperform

"Outperform" is the opposite of "underperform," meaning the analyst expects the stock to do better than the market average. It's usually considered a less confident rating than "buy."

Example of an Analyst Rating

You can use MarketBeat Analyst Ratings to find ranges and aggregates from buy- and sell-side analysts across the financial media. For example, here's a stock that analysts usually love: Alphabet Inc. (NASDAQ: GOOG).

Overview of stock analysis on GOOG Using MarketBeat's tools, you can find ratings from prominent analysts from multiple periods. Alphabet is currently labeled a "moderate buy" based on MarketBeat's consensus from 17 analysts. You'll get the consensus price target and the highest and lowest from the analysts surveyed.

Marketbeat's tools detailing analyst ratings

Looking at analyst recommendations over time is another helpful tool. For example, you can view the different levels of coverage over the last few years, which analysts changed their ratings and how the price targets vary from month to month. If an analyst can't get a good read on a particular stock they've been covering, they might choose to withhold their grade, which is one reason why the number of available ratings can change over time.

Overview of analyst ratings on MarketBeat Analysts from both sides of the aisle can be found on MarketBeat, ranging from large firms like JPMorgan Chase and Co. (NYSE: JPM) to smaller investment banks like Roth Capital. Some institutions like UBS Group offer both buy-side and sell-side ratings and analysis. These graphs show that even analysts with similar ratings can have vastly different price targets, so always understand the reasoning behind an analyst's view.

How to Use Analyst Ratings

Here are a few pointers on incorporating analyst ratings into your investment research.

Step 1: Don't rely on a single analyst.

Using an array of analysts (buy- and sell-side) gives inventors the most possible information. Don't just look for analysts with similar opinions as yourself — ensure you understand the pros and cons of each investment you make by incorporating positive and negative views, if possible.

Step 2: Compare analyst ratings across the industry or sector.

It's easy to slap a "buy" rating on a stock and predict a winner, but comparing stocks against others in the sector can offer insight into the rating. For example, if a stock is rated "buy" in the information technology sector, but a dozen others are rated "strong buy" by the same analyst, where is your capital best served?

Step 3: Consider your own goals and risk tolerance.

You might find stocks rated "strong buy" in your research in sectors you wish to avoid. That's fine! There are thousands of securities across dozens of industries in the public markets, and you don't need to purchase every share that comes with a "buy" rating. Instead, stick to your investment plan.

Step 4: Don't stubbornly stick to your original assessments.

Following your investment plan and using analyst ratings as guidelines are practical steps, but things can change over time. Today's "strong buy" stocks could be "strong sell" stocks down the road. Using an aggregate of analysts' ratings can help investors view stocks from a higher level. For example, if the number of "buy" ratings on a stock drops 40% over a few years, you might want to take a closer look at that particular company.

Why Are Analyst Ratings Important?

Checking out analyst ratings isn't a necessary step for investing, but it can be helpful for those looking to dig deep into an asset's prospects. Analyst research often has quotes from company executives, questions from conference calls and in-depth reporting on the company's balance sheet, income statement and other essential documents. Analysis like this is complex for individual investors to do on their own, especially considering how frequently analysts interact with the executives they cover. But access often comes with a downside, which we discuss more below.

How Accurate Are Analyst Ratings?

Both buy and sell-side analysts strive for accuracy because giving consistently wrong commendations can be hazardous for job security. However, investors should be aware that analysts might not always have the best interest of the retail investor at heart when making their recommendations.

For starters, being an analyst requires access to company employees and management. Analysts typically ask questions during conference calls and speak with C-suite executives on the record about their firms' prospects. Executives usually don't want to hear adverse reports about their companies, so analysts are incentivized to paint a rosy picture to retain access. The SEC has been questioning the authenticity of analyst ratings (especially on the sell-side) since 2002 when it asked bluntly, "Why are there so few sell ratings?"

Of course, there are other areas of the securities analysis market to face scrutiny. If you recall, during the 2008 financial crisis, the biggest credit rating agencies were all held to the fire due to claims that conflicts of interest influenced their ratings. The biggest rating agencies in the world were accused of "misrepresenting the risks associated with mortgage-backed securities." Remember, analyst ratings aren't spat out by computer algorithms but by living, breathing people who may have agendas other than providing the most precise and accurate reports on a company's future prospects.

Analyst Ratings Can Guide Investors, but Don't Treat Them as Gospel

Consider each type of investment research or advice in collaboration. Even the most accurate and thoughtful analysts get things wrong, plus ratings are frequently besieged with conflicts of interest. But analyst coverage does offer research that's difficult to get elsewhere, and using an array of analyst reports can give investors a deeper understanding of the securities they buy.

FAQs

Still have questions about analyst ratings? Here are a few answers to some common points of discussion:

What are analyst ratings?

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives.

Should you trust analyst ratings?

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

What does an analyst rating tell you about a stock?

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.

analyst ratings Headlines

BC-Nikkei 225 Futures
By The Associated Press | July 7, 2025
View BC-Nikkei 225 Futures
BC-Select Stock Indices
By The Associated Press | July 7, 2025
View BC-Select Stock Indices
CoreWeave's $9 Billion Power Play for Core Scientific
By Jeffrey Neal Johnson | July 7, 2025
View CoreWeave's $9 Billion Power Play for Core Scientific
Micron Insiders Sell But Investors Should Buy, Buy, Buy
By Thomas Hughes | July 7, 2025
View Micron Insiders Sell But Investors Should Buy, Buy, Buy
How major US stock indexes fared Monday, 7/7/2025
By The Associated Press | July 7, 2025
View How major US stock indexes fared Monday, 7/7/2025
Tesla’s Robotaxi Hype Fuels Bullish Price Targets to $500
By Sam Quirke | June 30, 2025
View Tesla’s Robotaxi Hype Fuels Bullish Price Targets to $500
Netflix Sets New Highs—Price Targets Keep Climbing
By Sam Quirke | June 12, 2025
View Netflix Sets New Highs—Price Targets Keep Climbing

Top Headlines and Offers

View All

3 Defense Leaders Set to Gain From Rising Military Spend
By Chris Markoch | July 5, 2025
View 3 Defense Leaders Set to Gain From Rising Military Spend
How a Government Loan Changes the Game for Plug Power
By Jeffrey Neal Johnson | July 4, 2025
View How a Government Loan Changes the Game for Plug Power
The Trump Dump is starting; Get out of stocks now?
From Paradigm Press(Ad)
View The Trump Dump is starting; Get out of stocks now?
2 Under the Radar Space & Defense Stocks With Huge Potential
By Leo Miller | July 1, 2025
View 2 Under the Radar Space & Defense Stocks With Huge Potential
Insider Selling at NVIDIA Could Turn Into an Opportunity
By Gabriel Osorio-Mazilli | July 2, 2025
View Insider Selling at NVIDIA Could Turn Into an Opportunity
3 Stocks With Near-Unanimous Buys That Could Rally Higher
By Nathan Reiff | July 2, 2025
View 3 Stocks With Near-Unanimous Buys That Could Rally Higher
The $7 company helping Nvidia build the world’s first trillion-dollar robot …
From Weiss Ratings(Ad)
View The $7 company helping Nvidia build the world’s first trillion-dollar robot …
Rigetti Computing: Cantor's Bullish Call May Be Just the Start
By Jeffrey Neal Johnson | July 3, 2025
View Rigetti Computing: Cantor's Bullish Call May Be Just the Start
The Ultimate Trump Bump: These Gov't Backed Stocks Are Exploding
By Leo Miller | July 2, 2025
View The Ultimate Trump Bump: These Gov't Backed Stocks Are Exploding
Rocket Lab: Latest Catalysts Bolster the Bull Case
By Ryan Hasson | July 3, 2025
View Rocket Lab: Latest Catalysts Bolster the Bull Case
Big Bank Buybacks: Morgan Stanley, Citi, & Wells Fargo Lead
By Gabriel Osorio-Mazilli | July 3, 2025
View Big Bank Buybacks: Morgan Stanley, Citi, & Wells Fargo Lead
The Apple Comeback Will Be Better Than the Setback
By Gabriel Osorio-Mazilli | July 4, 2025
View The Apple Comeback Will Be Better Than the Setback

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Stock Price Targets and Analyst Ratings